- Home
- TK vs XERS Comparison
TK vs XERS Comparison
Compare TK & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- XERS
- Stock Information
- Founded
- TK 1973
- XERS 2005
- Country
- TK Bermuda
- XERS United States
- Employees
- TK N/A
- XERS N/A
- Industry
- TK Marine Transportation
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- TK Consumer Discretionary
- XERS Health Care
- Exchange
- TK Nasdaq
- XERS Nasdaq
- Market Cap
- TK 701.1M
- XERS 752.7M
- IPO Year
- TK 1995
- XERS 2018
- Fundamental
- Price
- TK $7.58
- XERS $5.19
- Analyst Decision
- TK
- XERS Strong Buy
- Analyst Count
- TK 0
- XERS 6
- Target Price
- TK N/A
- XERS $6.25
- AVG Volume (30 Days)
- TK 912.1K
- XERS 2.1M
- Earning Date
- TK 07-31-2025
- XERS 08-07-2025
- Dividend Yield
- TK 26.35%
- XERS N/A
- EPS Growth
- TK 13.88
- XERS N/A
- EPS
- TK 1.85
- XERS N/A
- Revenue
- TK $1,086,963,000.00
- XERS $222,551,000.00
- Revenue This Year
- TK N/A
- XERS $35.31
- Revenue Next Year
- TK N/A
- XERS $19.65
- P/E Ratio
- TK $4.13
- XERS N/A
- Revenue Growth
- TK N/A
- XERS 29.88
- 52 Week Low
- TK $5.65
- XERS $2.10
- 52 Week High
- TK $9.78
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- TK 39.68
- XERS 61.80
- Support Level
- TK $7.44
- XERS $5.16
- Resistance Level
- TK $7.69
- XERS $5.49
- Average True Range (ATR)
- TK 0.25
- XERS 0.24
- MACD
- TK -0.06
- XERS 0.04
- Stochastic Oscillator
- TK 31.19
- XERS 77.84
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).